Results 31 to 40 of about 384,305 (217)

How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial [PDF]

Interventional Cardiology: Reviews, Research, Resources, 2019
Patients with symptoms and/or signs of ischaemia but no obstructive coronary artery disease (INOCA) present a diagnostic and therapeutic challenge.
Thomas J Ford, Colin Berry
doaj   +2 more sources

Obstructive Intramural Coronary Amyloidosis [PDF]

JACC: Case Reports
Background: Obstructive intramural coronary amyloidosis (OICA) can be the unique manifestation of cardiac amyloidosis (CA). The clinical onset may mimic ischemic heart disease as microvascular angina or myocardial infarction.
Luca Fazzini, MD, Emilia D'Elia, MD PhD, Edoardo Sciatti, MD, Giulia Togni, MD, Michele Senni, MD, Eloisa Arbustini, MD   +5 more
doaj   +2 more sources

Microvascular Angina Pectoris: The Pathophysiology of Decreased Coronary Reserve

Архивъ внутренней медицины
A review of modern Russian and foreign literature on the problem of impaired coronary blood flow reserve as a manifestation of microvascular dysfunction has been conducted.
M. A. Kravchenko, L. D. Khidirova
doaj   +2 more sources

Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries [PDF]

European Cardiology Review, 2019
The diagnosis of microvascular angina (MVA) is usually considered in patients presenting with angina symptoms and evidence of MI on non-invasive stress tests but normal coronary arteries at angiography.
Gaetano Antonio Lanza
doaj   +2 more sources

The effect of trimetazidine in the treatment of microvascular angina

International Journal of Angiology, 1999
Although the pathophysiology of microvascular angina is unclear, intracellular metabolic changes are believed to be the main factors. Trimetazidine has an intracellular metabolic effect in coronary insufficiency. The effect of trimetazidine in microvascular angina is unknown.
Nalbantgil S., Altintig A., Yilmaz H., Nalbantgil I., Önder R.   +4 more
openaire   +3 more sources

Coronary Sinus Reducer Improves Angina, Quality of Life, and Coronary Flow Reserve in Microvascular Dysfunction.

JACC: Cardiovascular Interventions
BACKGROUND Coronary microvascular dysfunction (CMD) is a common cause of angina with no obstructive coronary artery disease (ANOCA), and effective treatment options are limited.
Guy S Reeder
exaly   +2 more sources

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.

Am Heart J, 2020
Background Microvascular angina is caused by cardiac small vessel disease, and dysregulation of the endothelin system is implicated. The minor G allele of the non-coding single nucleotide polymorphism (SNP) rs9349379 enhances expression of the endothelin
Morrow AJ, Ford TJ, Mangion K, Kotecha T, Rakhit R, Galasko G, Hoole S, Davenport A, Kharbanda R, Ferreira VM, Shanmuganathan M, Chiribiri A, Perera D, Rahman H, Arnold JR, Greenwood JP, Fisher M, Husmeier D, Hill NA, Luo X, Williams N, Miller L, Dempster J, Macfarlane PW, Welsh P, Sattar N, Whittaker A, Connachie AM, Padmanabhan S, Berry C.   +29 more
europepmc   +2 more sources

Coronary Physiology Beyond Coronary Flow Reserve in Microvascular Angina: JACC State-of-the-Art Review.

Journal of the American College of Cardiology, 2018
Angina with no angiographic stenosis, commonly called "microvascular angina," encompasses a wide continuum of coronary pathophysiology in conflicting published reports.
Nils P Johnson, Kenneth Lance Gould
exaly   +2 more sources

Treatment of the hypertensive patient with microvascular angina

Current Opinion in Cardiology, 1999
Syndrome X and microvascular angina are a heterogenous group of diseases. Several medications, including angiotensin-converting enzyme inhibitors, beta-blockers, and calcium-channel blockers, have been reported to be successful in the treatment of microvascular angina. Control of hypertension and regression of left ventricular hypertrophy are important
Ventura, Hector, Loyalka, Pranav, Smart, Frank W.   +2 more
openaire   +6 more sources

Etiopathogenesis of microvascular angina: Caveats in our knowledge [PDF]

Indian Heart Journal, 2014
Nearly 50% of subjects of coronary artery disease suffer from coronary microvascular dysfunction. Various etiopathogenetic factors have been proposed by different workers but no hypothesis can explain the genesis of microvascular angina in all patients ...
S.R. Mittal
doaj   +2 more sources